Actively Recruiting
Real-World Study Evaluating the Efficacy and Safety of Incadronate in Breast Cancer Patients with Bone Metastases
Led by Fudan University · Updated on 2026-11-02
500
Participants Needed
1
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are exploring the real-world effectiveness and safety of incadronate in patients with breast cancer that has spread to the bones. This observational study aims to better understand how incadronate works in treating bone metastases among breast cancer patients and to monitor any related adverse events. The study is sponsored by Fudan University and focuses on patients aged 18 years and older who meet specific health criteria. Participants in this study will receive incadronate treatment as part of their clinical care, with no experimental interventions assigned by the study itself. The study will observe and record outcomes related to skeletal-related events SREs and adverse effects over a 12-month period. There are no control or comparator groups, as this is an observational study tracking the natural use of incadronate in routine practice. During the study, participants will be monitored for the occurrence of skeletal-related events and the timing of the first such event within one year. Safety will be assessed through tracking any adverse effects experienced during this time. Eligibility and physical status will be evaluated at enrollment, and participants will be observed as they continue their prescribed treatment with incadronate. Total participation may last up to 12 months or longer depending on individual patient follow-up needs.
CONDITIONS
Brief Title
clinIcal Efficacy and Safety of Incadronate in Breast Cancer With Bone Metastases
Research Team
J
Jian Zhang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here